GOSSAMER BIO, INC.

GOSS ·Healthcare, Drug Manufacturers - General, United States
Financial Statements Balance Sheet
Annual Quarterly

Balance Sheet

Line Item FY2017 FY2016
Assets
Cash & Equivalents $315.0K $60.0K
Accounts Receivable
Inventory
Total Current Assets
Property, Plant & Equipment
Goodwill
Intangible Assets (Excl. Goodwill)
Total Assets
Liabilities
Accounts Payable
Total Current Liabilities
Long-Term Debt
Total Liabilities
Stockholders' Equity
Retained Earnings
Total Stockholders' Equity $-6.9M $-123.0K
← Newer Page 2 of 2 Older →